Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF EFFECTIVE INCOME TAX RATE (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Provision (benefit) for income tax	$ (11)	$ (714)	$ 24	$ (684)
Effective income tax rate	0.90%	35.10%	(0.50%)	11.40%

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.